ARCHIVES

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

This article is from The Cancer Letter archive.

Vol. 33 No. 02 | January 19, 2007

Download PDF Visit The Full Archive

Related Articles

Another Feasibility Study For Women’s Wealth Trial? Yes And No; It’s ‘Class Of 84’s” Adieu

December 14, 1990

NCI to Implement More Transparent Formula For Calculating Cancer Center Support Grants

July 11, 2014

DCT Board Approves Phase 2/3 Studies Of LAK-IL-2

February 14, 1986

NIH Extramural Office Lists Initiatives For Reinvention

January 13, 1995

Cancer Groups Endorse Pazdur For FDA Commissioner.

January 19, 2001

Sullivan Confirmation Hearing Set For Feb. 1

January 27, 1989